SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Politics : Politics for Pros- moderated

 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext  
To: Follies who wrote (735550)12/21/2020 12:38:02 PM
From: Copeland  Read Replies (1) of 793876
 
Anything is possible. There isn't a complete database of all the protein structures in the human body. There are some big databases out there like UniProt and the NIH has its own databases, but I suspect most of the work is done in private industry in order to find new drug candidates and they probably keep most of that stuff to themselves.

One thing that was brought up a few weeks ago was that one of the proteins on the receptor binding domain of the spike protein looks similar to a placental protein generated by a pregnant woman. Theoretically you could develop antibodies that could cross react with both and a child bearing woman could end up infertile due to the body constantly rejecting its own placenta. I don't know how much of that is true (regarding the similarity between the proteins).

Ultimately the future of biotech is to develop specific proteins that bind onto important viral proteins, changing their shapes so the virus no longer works and the complex is subsequently excreted by the kidneys or nuked by the liver. That would be the cure for this disease. We're kinda there with the monoclonal antibodies developed by Moderna and others, but they are likely not specific enough to their creators' liking, but they are effective none the less.
Report TOU ViolationShare This Post
 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext